NCT03702426View on ClinicalTrials.gov

Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG

GMCSF

GMCSF 1.5mcg/Kg

DRUG

Norfloxacin

Tablet Norfloxacin 400 mg

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT03702426 - Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis | Biotech Hunter | Biotech Hunter